Senthil Kumar K J, Gokila Vani M, Dakpa Gyaltsen, Wang Sheng-Yang
Bachelor Program of Biotechnology, National Chung Hsing University, Taichung, Taiwan.
Center for General Education, National Chung Hsing University, Taichung, Taiwan.
Biofactors. 2025 Jan-Feb;51(1):e2106. doi: 10.1002/biof.2106. Epub 2024 Aug 14.
Limonene, a dietary monocyclic monoterpene commonly found in citrus fruits and various aromatic plants, has garnered increasing interest as a gastrointestinal protectant. This study aimed to assess the effects of limonene on intestinal epithelial barrier function and investigate the involvement of cannabinoid receptor type-1 (CB1R) in vitro. Additionally, the study focused on examining the metabolomic changes induced by limonene in the intestinal epithelial cells (Caco-2). Initial analysis of transepithelial electrical resistance (TEER) revealed that both l-limonene and d-limonene, isomers of limonene, led to a dose- and time-dependent increase in TEER in normal cells and those inflamed by pro-inflammatory cytokines mixture (CytoMix). Furthermore, both types of limonene reduced CytoMix-induced paracellular permeability, as demonstrated by a decrease in Lucifer yellow flux. Moreover, d-limonene and l-limonene treatment increased the expression of tight junction molecules (TJs) such as occludin, claudin-1, and ZO-1, at both the transcriptional and translational levels. d-Limonene upregulates E-cadherin, a molecule involved in adherens junctions (AJs). Mechanistic investigations demonstrated that d-limonene and l-limonene treatment significantly inhibited CB1R at the protein, while the mRNA level remained unchanged. Notably, the inhibitory effect of d-limonene on CB1R was remarkably similar to that of pharmacological CB1R antagonists, such as rimonabant and ORG27569. d-limonene also alters Caco-2 cell metabolites. A substantial reduction in β-glucose and 2-succinamate was detected, suggesting limonene may impact intestinal epithelial cells' glucose uptake and glutamate metabolism. These findings suggest that d-limonene's CB1R antagonistic property could effectively aid in the recovery of intestinal barrier damage, marking it a promising gastrointestinal protectant.
柠檬烯是一种常见于柑橘类水果和各种芳香植物中的膳食单环单萜,作为一种胃肠道保护剂,越来越受到关注。本研究旨在评估柠檬烯对肠上皮屏障功能的影响,并在体外研究1型大麻素受体(CB1R)的参与情况。此外,该研究还着重考察柠檬烯在肠上皮细胞(Caco-2)中引起的代谢组学变化。对跨上皮电阻(TEER)的初步分析表明,柠檬烯的异构体l-柠檬烯和d-柠檬烯,在正常细胞以及被促炎细胞因子混合物(细胞因子混合物)炎症化的细胞中,均导致TEER呈剂量和时间依赖性增加。此外,两种类型的柠檬烯都降低了细胞因子混合物诱导的细胞旁通透性,这通过荧光素黄通量的降低得以证明。而且,d-柠檬烯和l-柠檬烯处理在转录和翻译水平上均增加了紧密连接分子(TJs)如闭合蛋白、Claudin-1和ZO-1的表达。d-柠檬烯上调了参与黏附连接(AJs)的分子E-钙黏蛋白。机制研究表明,d-柠檬烯和l-柠檬烯处理在蛋白质水平上显著抑制CB1R,而mRNA水平保持不变。值得注意的是,d-柠檬烯对CB1R的抑制作用与药理学CB1R拮抗剂如利莫那班和ORG27569的抑制作用非常相似。d-柠檬烯还改变了Caco-2细胞代谢物。检测到β-葡萄糖和2-琥珀酸酯大量减少,表明柠檬烯可能影响肠上皮细胞的葡萄糖摄取和谷氨酸代谢。这些发现表明,d-柠檬烯的CB1R拮抗特性可有效帮助恢复肠屏障损伤,使其成为一种有前景的胃肠道保护剂。